It has been a new dawn in bespoke medical therapies for thyroid eye disease since the FDA approval of Teprotumumab in the USA.
BOPSS have assembled a panel of TED Trial Investigators and other experts who can share their experiences and perspectives, to encourage wider UK participation and increase patient access to these exciting new therapies in the blossoming trial landscape.
This website is designed to be accessed by the public for general oculoplastic information. It is also an important tool for the Society, permitting surgeons to have access to information about membership, the annual scientific meeting, surgical audit and training.
If you have any questions regarding the website, please contact webmaster@bopss.co.uk. Alternatively, you may email the secretary.
© Copyright 2025 BOPSS. Created by 2able & Medisites.co.uk